Vir Biotechnology, Inc.

VIR ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2020

Total Assets: $918.8M

Liabilities Breakdown FY2020

Total Liabilities: $201.9M